Position Title |
Signature Required For |
Principal Investigator |
All applications |
PI’s Department Chairperson |
All applications |
Division Chief |
Department of Medicine studies |
Division Director |
Jacobi Surgery studies |
Department Chairperson |
Each department involved in the work outlined in the protocol when the test/procedure is beyond standard clinical care and is performed only for research purposes |
Medicine Chief of Service |
All research involving Medicine In-patients at MMC (Weiler or Moses) |
Director of Nursing at MMC |
MMC Oncology protocols that involve the nursing staff
Nursing students conducting nursing research
|
Chairman of Radiology |
Tests/procedures that are beyond standard clinical care and involve resources of the department of Radiology |
Montefiore: Chairman of Radiology
NBHN: Chairman of Nuclear Medicine |
Tests/procedures that are beyond standard clinical care and involve resources of the department of Nuclear Medicine |
Chairman of Radiology |
MRI’s that are beyond standard clinical care |
Pharmacy Director |
All research involving drugs, whether approved or investigational |
Chairman of Pathology |
Any research protocol in which:
- Tests/procedures are performed that are beyond standard clinical care and involve resources of the clinical Laboratory.
- Resources of the Pathology department will be utilized.
- Tissue specimens for research will be obtained as part of a clinical procedure performed for the purpose of diagnosis or treatment.
- Specimens obtained for research purposes must come from specific tissue (i.e. it is important that there be histological confirmation that the correct tissue has been obtained).
NOTE: Research protocols in which samples of presumably normal tissue will be analyzed only for their chemical content (e.g. drug levels, biomarkers, etc), but there is no need for histological confirmation of tissue type, do not require prior review by Pathology before submission to the IRB. When a PI selects this option, the IRB reviewer must concur with the decision that histological confirmation is not required. |
Director, Clinical Pathology |
Any research protocol in which body fluid samples are obtained from the Clinical Pathology Lab |
Director, hFTR |
All studies involving material from the Einstein hFTR. |
Director, Catheterization Laboratory |
All studies involving catheterizations at Weiler |
Director, Diabetes Research and Training Center |
All research being funded by the DRTC Grant |
Director, Sound View Throggs Neck (SVTN) |
All research taking place at SVTN |
Executive Director, Division of Substance Abuse (DOSA) |
All research involving the DOSA facilities or population |
Chairman, Emergency Medicine |
Any research originating in the Emergency Department |
Director, Clinical Research Center (CRC) |
All research involving drugs, whether approved or investigational, that will be stored in the CRC |
Administration, Burke Hospital |
Burke Hospital as a research site or department for the PI |
YU Schools |
Dean, Yeshiva College |
All research involving Yeshiva College students or faculty |
Dean, Stern College |
All research involving Stern College students or faculty |
Director, Syms School of Business |
All research involving Syms School of Business students or faculty |
Provost |
All YU Research |
Dean, Azrieli |
All research involving Azrieli students or faculty |
Dean, Ferkauf |
All research involving Ferkauf students or faculty |
Ferkauf IRB Representative |
All research involving Ferkauf students or faculty |
Dean, Wurzweiler |
All research involving Wurzweiler students or faculty |
Director, Doctoral Program, Wurzweiler |
All research involving Wurzweiler students |
Dean, Katz |
All research involving Katz students or faculty |
Dean for Students, Einstein |
Any research involving Einstein medical students as key personnel |
Dean for Students, Einstein |
Any research targeting Einstein medical students as research subjects |